Department of Pharmacology and Toxicology, Faculty of Pharmacy & Pharmaceutical Industries, Sinai University, Arish, Egypt
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt
Department of Bio- chemistry, Faculty of Pharmacy & Pharmaceutical Industries, Sinai University, Arish, Egypt
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt
Copyright © 2013 Mohammad M. Abd-Alhaseeb, Sawsan A. Zaitone, Soad H. Abou-El-Ela, Yasser M. Moustafa et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
M. Abd-Alhaseeb, S. Zaitone, S. Abou-El-Ela and Y. Moustafa, "Assessment of the Safety of Olmesartan in Combination with Sorafenib in Mice Bearing Ehrlich’s Ascites Carcinoma,"
Journal of Cancer Therapy, Vol. 4 No. 8, 2013, pp. 1355-1361. doi:
10.4236/jct.2013.48160.